| Literature DB >> 23110382 |
Giesje Nefs1, Mariska Bot, Jessica L Browne, Jane Speight, François Pouwer.
Abstract
BACKGROUND: As the number of people with diabetes is increasing rapidly worldwide, a more thorough understanding of the psychosocial aspects of living with this condition has become an important health care priority. While our knowledge has grown substantially over the past two decades with respect to the physical, emotional and social difficulties that people with diabetes may encounter, many important issues remain to be elucidated. Under the umbrella of the Diabetes MILES (Management and Impact for Long-term Empowerment and Success) Study International Collaborative, Diabetes MILES--The Netherlands aims to examine how Dutch adults with diabetes manage their condition and how it affects their lives. Topics of special interest in Diabetes MILES--The Netherlands include subtypes of depression, Type D personality, mindfulness, sleep and sexual functioning. METHODS/Entities:
Mesh:
Year: 2012 PMID: 23110382 PMCID: PMC3560187 DOI: 10.1186/1471-2458-12-925
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Variables included in Diabetes MILES – The Netherlands (2011)
| Demographics | Sex†‡, age†‡, marital status†‡, ethnicity†, education†‡, current employment†‡, shift work | All participants |
| Diabetes (clinical) | Diabetes type†‡, diabetes duration†‡, current treatment regimen†‡, current blood glucose level, most recent HbA1c†‡, HbA1c target level, number of severe hypos/hypers in past year, main diabetes health professional, membership of patient organisation†‡ | All participants |
| General health | Height†‡, weight†‡, waist circumference†‡, hip circumference, presence of and medication for co-morbid conditions (including diabetes complications)†‡, number of hospitalisations in past year | All participants |
| Health consultations | Number of contacts with health professionals† in past year, cancelled appointments in past year, consultation behaviour (10 items) | All participants |
| Self-care behaviours | Diabetes Self-Care Inventory Revised (unpublished) plus Diabetes MILES – Australia smoking items†‡ | All participants |
| Medication taking | ASK-12: Adherence Starts with Knowledge 12-item version
[ | All participants |
| Physical Activity | IPAQ: International Physical Activity Questionnaire (Short Form)
[ | All participants |
| Eating behaviour | 38-item food frequency questionnaire | All participants |
| Disordered eating | 6 items†‡ plus 2 items with respect to insulin adapted from Diabetes MILES – Australia | All participants |
| Alcohol consumption | 1 item: number of units per week | All participants |
| Diabetes-related distress | PAID: Problem Areas In Diabetes scale
[ | All participants |
| Depression | PHQ-9: Patient Health Questionnaire 9-item scale
[ | All participants |
| Anxiety | GAD-7: Generalized Anxiety Disorder 7-item scale
[ | All participants |
| Type D personality | DS14: Type D Scale-14
[ | All participants |
| Stressful life event(s) | 1 item: stressful life event(s) in past year | All participants |
| Loneliness | 1 item: loneliness in past year | All participants |
| Psychological insulin resistance | ITAS: Insulin Treatment Appraisal Scale
[ | Module 1 |
| Fear of hypoglycaemia | HFS-II: Hypoglycaemia Fear Survey-II
[ | Module 1 |
| Diabetes-specific avoidance | 6 items | Module 1 |
| Eating style | DEBQ: Dutch Eating Behavior Questionnaire
[ | Module 1,3 |
| Beliefs about diabetes | BIPQ: Brief Illness Perception Questionnaire (diabetes version)
[ | Module 1,3 |
| Anhedonia | 4-item anhedonia subscale HADS: Hospital Anxiety and Depression Scale
[ | Module 2 |
| Manic symptoms | MDQ-NL: Mood Disorder Questionnaire
[ | Module 2 |
| Subtypes of depression | IDS-SR: Inventory of Depressive Symptomatology – self reported
[ | Module 2 |
| Mindfulness | FFMQ-NL: Five Facet Mindfulness Questionnaire – Dutch version
[ | Module 3 |
| Neuropathic pain | NeuroQoL: Neuropathy and foot ulcer-specific Quality of Life questionnaire (physical symptom measures only)
[ | Module 3,4 |
| Positive mental health | MHC-SF: Mental Health Continuum - Short Form (emotional and psychological subscales only)
[ | Module 3 |
| Sleep | PSQI: Pittsburgh Sleep Quality Index
[ | Module 4 |
| Fatigue | FAS: Fatigue Assessment Scale
[ | Module 4 |
| Daytime sleepiness | ESS: Epworth Sleepiness Scale
[ | Module 4 |
| Social support | MSPSS: Multidimensional Scale of Perceived Social Support
[ | Module 5 |
| Relationship adjustment | DAS: Dyadic Adjustment Scale
[ | Module 5 |
| Sexual problems | SSFS: Short Sexual Functioning Scale – male and female version (Enzlin et al., unpublished) | Module 5 |
* Unless otherwise specified, the question(s) was/were designed by the Diabetes MILES – The Netherlands research team.
† Diabetes MILES Study core measures, to be included in all surveys of adults living with type 1 or type 2 diabetes.
‡ Measures present in the pooled Australian-Dutch data-set.
Figure 1Flow chart of Diabetes MILES – The Netherlands.
Sample characteristics of Diabetes MILES – The Netherlands (2011)
| | | | |
| Women | 54% (2,133/3,925) | 61% (958/1,572) | 48% (1,020/2,108) ‡ |
| Age in years | 55 ± 14 | 47 ± 15 | 62 ± 10 ‡ |
| Ethnic minority | 3% (104/3,884) | 2% (34/1,573) | 3% (58/2,108) |
| Educational level | | | |
| Low | 27% (1,040/3,870) | 19% (293/1,571) | 33% (684/2,101) |
| Middle | 34% (1,313/3,870) | 35% (546/1,571) | 34% (704/2,101) |
| High | 39% (1,517/3,870) | 47% (732/1,571) | 34% (713/2,101) ‡ |
| Having a partner | 80% (3,107/3,889) | 80% (1,260/1,573) | 80% (1,682/2,108) |
| Paid employment | 48% (1,838/3,873) | 63% (992/1,571) | 36% (763/2,104) ‡ |
| | | | |
| Duration of diabetes in years | 16 ± 13 | 23 ± 15 | 11 ± 8 ‡ |
| Diabetes treatment | | | |
| Insulin pump | 24% (910/3,786) | 48% (761/1,572) | 6% (125/2,102) ‡ |
| Insulin injections | 50% (1,891/3,786) | 53% (830/1,572) | 47% (995/2,102) † |
| Glucagon-like peptide-1 (GLP-1) agonist injections | 2% (62/3,786) | 0.1% (2/1,572) | 3% (59/2,102) ‡ |
| Blood glucose lowering tablets | 44% (1,627/3,664) | 7% (111/1,566) | 74% (1,474/1,987) ‡ |
| Lifestyle only | 3% (99/3,726) | 0% (0/1,572) | 5% (95/2,042) ‡ |
| Most recent HbA1c (mmol/mol) | 56 ± 12 | 58 ± 12 | 54 ± 12 ‡ |
| Body Mass Index (kg/m2) | 28 ± 6 | 25 ± 5 | 30 ± 6 ‡ |
| Macro-vascular disease and/or micro-vascular complications * | | | |
| None | 69% (2,544/3,691) | 70% (1,077/1,539) | 68% (1,383/2,041) |
| One | 20% (729/3,691) | 18% (276/1,539) | 21% (436/2,041) |
| Two or more | 11% (418/3,691) | 12% (186/1,539) | 11% (222/2,041) † |
Values are mean ± standard deviation, unless otherwise specified.
* Self-reported myocardial infarction, stroke, peripheral arterial disease, nephropathy, retinopathy, neuropathy and/or foot condition.
† Difference between self-reported type 1 and type 2 diabetes p < 0.05.
‡ Difference between self-reported type 1 and type 2 diabetes p < 0.001.